Valproic Acid Exposure during Early Postnatal Gliogenesis Leads to Autistic-like Behaviors in Rats
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective: We reported that postnatal exposure of rats to valproic acid (VPA) stimulated proliferation of glial precursors during cortical gliogenesis. However, there are no reports whether enhanced postnatal gliogenesis affects behaviors related to neuropsychiatric disorders. Methods: After VPA treatment during the postnatal day (PND) 2 to PND 4, four behavioral test, such as open field locomotor test, elevated plus maze test, three-chamber social interaction test, and passive avoidance test, were performed at PND 21 or 22. Results: VPA treated rats showed significant hyperactive behavior in the open field locomotor test (p＜0.05). Moreover, the velocity of movement in the VPA group was increased by 69.5% (p＜0.01). In the elevated plus maze test, VPA exposed rats expressed significantly lower percentage of time spent on and of entries into open arms more than the control group (p＜0.05). Also, both sociability and social preference indices with strangers in the three-chamber social interaction test were significantly lower in the VPA exposed rats (p＜0.05). Conclusion: Our results suggest that altered glial cell development is another locus at which pathogenetic factors can operate to contribute to the neurodevelopmental disorder.
Abstract
Objective: We reported that postnatal exposure of rats to valproic acid (VPA) stimulated proliferation of glial precursors during cortical gliogenesis. However, there are no reports whether enhanced postnatal gliogenesis affects behaviors related to neuropsychiatric disorders. Methods: After VPA treatment during the postnatal day (PND) 2 to PND 4, four behavioral test, such as open field locomotor test, elevated plus maze test, three-chamber social interaction test, and passive avoidance test, were performed at PND 21 or 22. Results: VPA treated rats showed significant hyperactive behavior in the open field locomotor test (p＜0.05). Moreover, the velocity of movement in the VPA group was increased by 69.5% (p＜0.01). In the elevated plus maze test, VPA exposed rats expressed significantly lower percentage of time spent on and of entries into open arms more than the control group (p＜0.05). Also, both sociability and social preference indices with strangers in the three-chamber social interaction test were significantly lower in the VPA exposed rats (p＜0.05). Conclusion: Our results suggest that altered glial cell development is another locus at which pathogenetic factors can operate to contribute to the neurodevelopmental disorder.
참고문헌 (38)
- Bond DJ, "Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis", J Affect Disord, 124, pp.228~234 (2010)
- Kim KC, "The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats", Toxicol Lett, 201, pp.137~142 (2011)
- Lovell BV, "Valproate semisodium ER for migraine and cluster headache prophylaxis", Expert Opin Drug Metab Toxicol, 6, pp.495~504 (2010)
- Mackey C, "The anticonvulsants market", Nat Rev Drug Discov, 9, pp.265~266 (2010)
- Koren G, "Major malformations with valproic acid", Can Fam Physician, 52, pp.441~442 (2006)
- Ornoy A, "Valproic acid in pregnancy: how much are we endangering the embryo and fetus?", Reprod Toxicol, 28, pp.1~10 (2009)
- Chauhan A, "Oxidative stress in autism", Pathophysiology, 13, pp.171~181 (2006)
- Söğüt S, "Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism", Clin Chim Acta, 331, pp.111~117 (2003)
- Schneider T, "Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism", Neuropsychopharmacology, 30, pp.80~89 (2005)
- Wagner GC, "A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate", J Autism Dev Disord, 36, pp.779~793 (2006)
- Yochum CL, "VPA-induced apoptosis and behavioral deficits in neonatal mice", Brain Res, 1203, pp.126~132 (2008)
- Molofsky AV, "Astrocytes and disease: a neurodevelopmental perspective", Genes Dev, 26, pp.891~907 (2012)
- Nedergaard M, "Direct signaling from astrocytes to neurons in cultures of mammalian brain cells", Science, 263, pp.1768~1771 (1994)
- Rajkowska G, "Gliogenesis and glial pathology in depression", CNS Neurol Disord Drug Targets, 6, pp.219~233 (2007)
- Wang DD, "The astrocyte odyssey", Prog Neurobiol, 86, pp.342~367 (2008)
- Araque A, "Tripartite synapses: glia, the unacknowledged partner", Trends Neurosci, 22, pp.208~215 (1999)
- Parpura V, "Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons", Proc Natl Acad Sci U S A, 97, pp.8629~8634 (2000)
- Pfrieger FW, "Roles of glial cells in synapse development", Cell Mol Life Sci, 66, pp.2037~2047 (2009)
- Hee Jae Lee, "Valproic acid stimulates proliferation of glial precursors during cortical gliogenesis in developing rat", Developmental Neurobiology, 76(7), pp.780~798 (2016), Wiley-Blackwell[DOI]
- Pellow S, "Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat", Pharmacol Biochem Behav, 24, pp.525~529 (1986)
- Kim JW, "Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism", PLoS One, 9, pp.e104927~ (2014)
- Arndt TL, "The teratology of autism", Int J Dev Neurosci, 23, pp.189~199 (2005)
- Miyazaki K, "Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism", Int J Dev Neurosci, 23, pp.287~297 (2005)
- Stodgell CJ, "Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action", Neurotoxicol Teratol, 28, pp.617~624 (2006)
- Bambini-Junior V, "Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters", Brain Res, 1408, pp.8~16 (2011)
- Al-Amin MM, "Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism", Behav Brain Res, 286, pp.112~121 (2015)
- Chomiak T, "Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism", BMC Neurosci, 11, pp.102~ (2010)
- Reynolds S, "Sensory and motor characterization in the postnatal valproate rat model of autism", Dev Neurosci, 34, pp.258~267 (2012)
- Pragnya B, "Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB", C mice, 2014, pp.270, 86~94
- Clarke LE, "Emerging roles of astrocytes in neural circuit development", Nat Rev Neurosci, 14, pp.311~321 (2013)
- Sloan SA, "Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders", Curr Opin Neurobiol, 27, pp.75~81 (2014)
- Laurence JA, "Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects", Cerebellum, 4, pp.206~210 (2005)
- Fatemi SH, "Expression of astrocytic markers aquaporin 4 and connexin 43 is altered in brains of subjects with autism", Synapse, 62, pp.501~507 (2008)
- Cao F, "Alteration of astrocytes and Wnt", β-catenin signaling in the frontal cortex of autistic subjects, 2012, pp.9, 223~
- Kumamaru E, "Valproic acid selectively suppresses the formation of inhibitory synapses in cultured cortical neurons", Neurosci Lett, 569, pp.142~147 (2014)
- Kim KC, "Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring", Mol Neurobiol, 49, pp.512~528 (2014)
- Darine Froy N. Mabunga, "Exploring the Validity of Valproic Acid Animal Model of Autism", Experimental Neurobiology, 24(4), pp.285~300 (2015), 한국뇌신경과학회
- Allen NJ, "Astrocyte regulation of synaptic behavior", Annu Rev Cell Dev Biol, 30, pp.439~463 (2014)